GaldermaReceivesU.S.FDAApprovalforRestylaneLyftfortheEnhancementoftheChinProfile
===2025/11/5 21:22:08===
versatile HA injectable with over 20 years of worldwide safety data, which is also approved to treat the midface, facial folds and wrinkles (such as nasolabial folds) and back of hands.2,3,4
The Restylane portfolio offers a versatile range of HA injectables, from soft and flexible to firm gel formulations, empowering practitioners to deliver personalized aesthetic outcomes.5-8Restylane Lyft, developed with NASHA®technology, has a firmer gel with minimal modification, closely resembling the skin’s natural HA.9,10With its high G-prime (a measure of firmness), Restylane Lyft is specifically designed to provide structure and support, enabling it to enhance the chin for a balanced profile.2,5,11
“This approval reinforces our commitment to advancing our Injectable Aesthetics portfolio – the broadest on the market – to meet the diverse needs of patients. By expanding how innovatio
=*=*=*=*=*=
当前为第2/13页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页